TickerFacts.

Cuprina Holdings (Cayman) Ltd (CUPR): Cost of Revenue

Annual figures by period end, from SEC filings.

50.5K SGD
Year ended 2025-12-31
+11.3%
3-year compound annual growth
64.2K SGD2022-12-31: 36.6K SGD2023-12-31: 64.2K SGD2024-12-31: 51.3K SGD2025-12-31: 50.5K SGD50.5K SGD
2022-12-31 Cost of Revenue (SGD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-3150.5K SGD-1.6%2026-04-27, From 2025-01-01
2024-12-3151.3K SGD-20.0%2026-04-27, From 2024-01-01
2023-12-3164.2K SGD+75.2%2026-04-27, From 2023-01-01
2022-12-3136.6K SGDn/a2025-05-14, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Cuprina Holdings (Cayman) Ltd (CUPR)2025-12-3150.5K SGD-1.6%
Phaos Technology Holdings (Cayman) Ltd (POAS)2026-04-30114.8K SGD-12.2%

Compare CUPR, POAS side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗